46 related articles for article (PubMed ID: 7719956)
21. Increased concentrations of bone sialoprotein in joint fluid after knee injury.
Lohmander LS; Saxne T; Heinegård D
Ann Rheum Dis; 1996 Sep; 55(9):622-6. PubMed ID: 8882132
[TBL] [Abstract][Full Text] [Related]
22. Cartilage metabolism--a response.
Myers SL; Brandt KD
Ann Rheum Dis; 1995 Aug; 54(8):685-6. PubMed ID: 7677448
[No Abstract] [Full Text] [Related]
23. Cartilage metabolism in the injured and uninjured knee of the same patient.
Dahlberg L; Roos H; Saxne T; Heinegård D; Lark MW; Hoerrner LA; Lohmander LS
Ann Rheum Dis; 1994 Dec; 53(12):823-7. PubMed ID: 7864691
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities.
Lohmander LS; Dahlberg L; Eyre D; Lark M; Thonar EJ; Ryd L
Osteoarthritis Cartilage; 1998 Sep; 6(5):351-61. PubMed ID: 10197170
[TBL] [Abstract][Full Text] [Related]
25. Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella.
Väätäinen U; Lohmander LS; Thonar E; Hongisto T; Agren U; Rönkkö S; Jaroma H; Kosma VM; Tammi M; Kiviranta I
Osteoarthritis Cartilage; 1998 Mar; 6(2):115-24. PubMed ID: 9692066
[TBL] [Abstract][Full Text] [Related]
26. A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture--synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1.
Dahlberg L; Fridén T; Roos H; Lark MW; Lohmander LS
Br J Rheumatol; 1994 Dec; 33(12):1107-11. PubMed ID: 8000736
[TBL] [Abstract][Full Text] [Related]
27. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid.
Shinmei M; Kobayashi T; Yoshihara Y; Samura A
J Rheumatol Suppl; 1995 Feb; 43():78-81. PubMed ID: 7752146
[TBL] [Abstract][Full Text] [Related]
28. Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise.
Roos H; Dahlberg L; Hoerrner LA; Lark MW; Thonar EJ; Shinmei M; Lindqvist U; Lohmander LS
Osteoarthritis Cartilage; 1995 Mar; 3(1):7-14. PubMed ID: 7719956
[TBL] [Abstract][Full Text] [Related]
29. Keratan sulfate in body fluids in joint disease.
Thonar EJ; Masuda K; Häuselmann HJ; Uebelhart D; Lenz ME; Manicourt DH
Acta Orthop Scand Suppl; 1995 Oct; 266():103-6. PubMed ID: 8553836
[No Abstract] [Full Text] [Related]
30. [Overview of the current status of measurable parameters of cartilage metabolism in various body fluids].
Ettrich U; Fengler H; Dressler F; Schulze KJ
Z Rheumatol; 1998 Dec; 57(6):375-91. PubMed ID: 10025097
[TBL] [Abstract][Full Text] [Related]
31. Serum keratan sulfate--a marker of predisposition to polyarticular osteoarthritis.
Thonar EJ; Glant T
Clin Biochem; 1992 Jun; 25(3):175-80. PubMed ID: 1633632
[TBL] [Abstract][Full Text] [Related]
32. Serum markers of articular cartilage damage and repair.
Wollheim FA
Rheum Dis Clin North Am; 1999 May; 25(2):417-32, viii. PubMed ID: 10356426
[TBL] [Abstract][Full Text] [Related]
33. Aggrecan degradation in osteoarthritis and rheumatoid arthritis.
Lark MW; Bayne EK; Lohmander LS
Acta Orthop Scand Suppl; 1995 Oct; 266():92-7. PubMed ID: 8553869
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
